TELL ME MORE
ABOUT THIS CLINICAL TRIAL for ULCERATIVE COLITIS
This is a Placebo-controlled and Active-comparitor Study of a Biologic Investigational Medicine for Adults with Moderate to Severe Ulcerative Colitis
Clinical Trial for Ulcerative Colitis in Adults
Study Location(s): Evansville Indiana
Ulcerative colitis is a chronic disease of the large intestine, in which the lining of the colon becomes inflamed and develops tiny open sores, or ulcers. This condition is the result of your immune system’s overactive response. This ulcerative colitis in adults study evaluates an investigational biologic medicine compared to placebo and to an approved biologic, followed by an open-label extension study in adults 18 – 80 years of age. Click here for more information on living with Ulcerative Colitis.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimburrsement up to $1100 may be available.
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ACNE Trifarotene Cream used with and 0ral antibiotic to treat severe acne vulgaris | Evansville | Coming Soon | 12+ | $600 | Request Info | |
| ADHD A Long-term active comparitor and dose optimization study to evaluatate safety and efficacy of a non-stimulat medication | Owensboro | Coming Soon | 6 - 17 | $1150 | Request Info | |
| ADHD A randomized, double-blind, multicenter, placebo-controlled study to evaluatate efficacy and safety of an investigational medicine in preschool-age children | Bowling Green Evansville Owensboro | Coming Soon | 4 - 5 | $400 | Request Info | |
| ASTHMA Safety and Efficacy Study of a Fixed Dose Combination (FDC) in Subjects With Asthma | Evansville | Recruiting | 5 - 17 | $800 | Request Info | |
| COMMON WARTS Efficacy, Safety and Tolerability Study in Children and Adults with Common Warts | Evansville | Coming Soon | 2+ | $350 | Request Info | |
| DIABETES (T2DM) Active Comparator Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors | BowlingGreen Owensboro | Recruiting | 40 + | $600/year (long-term study could last up to 5 years) | Request Info | |
| IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Recruiting | 18 - 80 | $3200 | Request Info | |
| IBD - ULCERATIVE COLITIS A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Ulcerative Colitis | Evansville | Recruiting | 18 - 80 | $1100 | Request Info | |
| IBS- CONSTIPATION A Efficacy and safety, placebo-controlled study for patients with constipation due to irritable bowel syndrome | BowlingGreen Evansville | Paused | 6 - 17 | $350 | Request Info | |
| INFANT FORMULA Comparison Study | BowlingGreen Evansville Owensboro | Recruiting | Newborns | Variable up to $150, + formula and diapers | Request Info | |
| INFANT VACCINE Comparison Study between two meningococcal vaccines | Evansville | Recruiting | Newborns | Variable up to $400 | Request Info | |
| LUPUS ERYTHEMATOSUS A Safety, efficacy and dose ranging comparison study for patients with moderate to severely active Systemic Lupus Erythematosus | Evansville | Recruiting | 18 - 65 | $750 | Request Info | |
| MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Recruiting | 6 - 17 | $200/$350 | Request Info | |
| PRURITUS (CHRONIC ITCH) An efficacy and safety study for the treatment of chronic itch in adult subjects with atopic dermatitis | Owensboro | Coming Soon | 18 - 75 | $600 | Request Info | |
| RHEUMATOID ARTHRITIS (RA) This is a comparison study to evaluate an investigational medicine for Rheumatoid Arthritis in adults with moderately or severely active disease and who have had inadequate response to conventional synthetic or biologic Disease Modifying Anti-rheumatic Drugs (DMARDs). | Evansville | Coming Soon | 18+ | Up to $1750 | Request Info | |